Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4

Clinical trial NCT05079152 · UNKNOWN

Trial details

NCT number: NCT05079152
Sponsor: China National Biotec Group Company Limited
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human Pneumonia, Pneumococcal COVID-19 Pneumonia

Start date: 2021-05-06
Primary completion: 2021-05-29
Enrollment: 1404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.